Piper Jaffray downgrades Hansen Medical (Nasdaq: HNSN) from Overweight to Neutral. Price target lowered from $5 to $3.75.

Piper analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE